cyclopentane has been researched along with Graft-Versus-Host Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujiwara, H; Mathewson, ND; Oravecz-Wilson, K; Reddy, P; Rossi, C; Sun, Y; Toubai, T; Wu, SR; Zajac, C | 1 |
Abedi, M; Chen, M; Khuat, LT; Murphy, WJ; Pai, CS | 1 |
2 other study(ies) available for cyclopentane and Graft-Versus-Host Disease
Article | Year |
---|---|
SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses.
Topics: Animals; Carrier Proteins; Cyclopentanes; Female; Gene Expression Profiling; Graft vs Host Disease; Humans; Immunity, Cellular; Mice, Inbred C57BL; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Protein Processing, Post-Translational; Pyrimidines; Signal Transduction; T-Lymphocytes; Ubiquitin-Protein Ligases; Ubiquitination | 2016 |
Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice.
Topics: Animals; Antigen-Presenting Cells; Cyclopentanes; Enzyme Inhibitors; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Lymphoma, B-Cell; Mice; Pyrimidines; Scleroderma, Systemic; T-Lymphocytes; Time Factors; Transplantation, Homologous; Ubiquitin-Activating Enzymes | 2017 |